日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy

基于CCN的治疗肽可改变胰腺导管腺癌微环境并与化疗联合降低肿瘤生长

Andrea Resovi, Patrizia Borsotti, Tommaso Ceruti, Alice Passoni, Massimo Zucchetti, Alexander Berndt, Bruce L Riser, Giulia Taraboletti, Dorina Belotti

Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis

钆诱导的纤维化由人类真皮成纤维细胞中的 CCN3 反向调节:一种潜在治疗肾源性系统性纤维化的模型

Bruce L Riser, Narasimharao Bhagavathula, Patricia Perone, Kendra Garchow, Yiru Xu, Gary J Fisher, Feridoon Najmabadi, Durga Attili, James Varani

CCN3/CCN2 regulation and the fibrosis of diabetic renal disease

CCN3/CCN2 调控与糖尿病肾病纤维化

Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, Jo Ann Rambow, Melisa L Riser, Ernest Sukowski, Herman Yeger, Sarah C Riser, Darryl R Peterson

CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease

CCN3(NOV)是 CCN2(CTGF)的负调节剂,也是肾脏疾病体外模型中纤维化途径的新型内源性抑制剂

Bruce L Riser, Feridoon Najmabadi, Bernard Perbal, Darryl R Peterson, Jo Ann Rambow, Melisa L Riser, Ernest Sukowski, Herman Yeger, Sarah C Riser

Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy

尿液单核细胞趋化蛋白-1 (MCP-1) 和结缔组织生长因子 (CCN2) 作为糖尿病肾病进展的预后标志物

Frederick W K Tam, Bruce L Riser, Karim Meeran, JoAnn Rambow, Charles D Pusey, Andrew H Frankel

Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-beta1

参与长期维持辐射诱导的纤维化分化的特定信号:CCN2 和低浓度 TGF-β1 的作用

Valérie Haydont, Bruce L Riser, Jocelyne Aigueperse, Marie-Catherine Vozenin-Brotons